22 October 2017
News and Views
Links and Services
This week's issue of the New England Journal of Medicine investigates panitumumab–FOLFOX4 treatment and RAS mutations in colorectal cancer.
Patients with metastatic colorectal cancer that harbor KRAS mutations in exon 2 do not benefit fr
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors